Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression

被引：0
|
作者：
Menegazzo, L. [1 ,2 ]
Albiero, M. [2 ]
Milioni, R. [1 ,3 ]
Tolin, S. [2 ,3 ]
Arrigoni, G. [2 ,3 ]
Poncina, N. [1 ,2 ]
Tessari, P. [1 ]
Avogaro, A. [1 ,2 ]
Fadini, G. [1 ,2 ]
机构：
[1] Univ Padua, Dept Med, Padua, Italy
[2] Venetian Inst Mol Med, Padua, Italy
[3] Univ Padua, Prote Ctr, Padua, Italy
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
262
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Circulating myeloid calcifying cells have antiangiogenic activity via thrombospondin-1 overexpression
    Menegazzo, Lisa
    Albiero, Mattia
    Millioni, Renato
    Tolin, Serena
    Arrigoni, Giorgio
    Poncina, Nicol
    Tessari, Paolo
    Avogaro, Angelo
    Fadini, Gian Paolo
    [J]. FASEB JOURNAL, 2013, 27 (11): : 4355 - 4365
  • [2] Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
    S L Maloney
    D C Sullivan
    S Suchting
    J M J Herbert
    E M Rabai
    Z Nagy
    J Barker
    S Sundar
    R Bicknell
    [J]. British Journal of Cancer, 2009, 101 : 957 - 966
  • [3] Therapies using anti-angiogenic peptide mimetics of thrombospondin-1
    Henkin, Jack
    Volpert, Olga V.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (12) : 1369 - 1386
  • [4] PEPTIDES DERIVED FROM 2 SEPARATE DOMAINS OF THE MATRIX PROTEIN THROMBOSPONDIN-1 HAVE ANTI-ANGIOGENIC ACTIVITY
    TOLSMA, SS
    VOLPERT, OV
    GOOD, DJ
    FRAZIER, WA
    POLVERINI, PJ
    BOUCK, N
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 122 (02): : 497 - 511
  • [5] Mutation of anti-angiogenic sequences in the type I repeats of thrombospondin-1
    Chandrasekaran, L
    Roberts, DD
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 298A - 298A
  • [6] Metformin Induces Thrombospondin-1 in Metabolically Challenged Endothelial Cells: Implications in Anti-angiogenic Cancer Therapy
    Samuel, Samson Mathews
    Ghosh, Suparna
    Majeed, Yasser
    Triggle, Chris R.
    [J]. FASEB JOURNAL, 2016, 30
  • [7] The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts
    Jin, RJ
    Kwak, C
    Lee, SG
    Lee, CH
    Soo, CG
    Park, MS
    Lee, E
    Lee, SE
    [J]. CANCER GENE THERAPY, 2000, 7 (12) : 1537 - 1542
  • [8] Improvement of anti-angiogenic and anti-tumourigenic efficacy of thrombospondin-1 by PPARγ ligands in bladder cancer
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 38 - 38
  • [9] Improvement of anti-angiogenic and anti-tumorigenic efficacy of thrombospondin-1 by PPARy ligands in bladder cancer
    Nelius, Thomas
    Huang, Hanua
    Filleur, Stephanie
    Campbell, Steven C.
    de Riese, Werner
    Volpert, Olga
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 259 - 259
  • [10] Anti-angiogenic Effects of Metformin in 2-Deoxyglucose Treated Microvascular Endothelial Cells: Role of Thrombospondin-1
    Samuel, Samson Mathews
    Ghosh, Suparna
    Majeed, Yasser
    Ding, Hong
    Triggle, Chris R.
    [J]. FASEB JOURNAL, 2017, 31
12345